摘要 |
This invention provides caspase inhibitors of formula I: wherein Z is oxygen or sulfur; R<SUP>1</SUP>is hydrogen, -CHN<SUB>2</SUB>, R, CH<SUB>2</SUB>OR, CH<SUB>2</SUB>SR, or -CH<SUB>2</SUB>Y; Y is an electronegative leaving group; R<SUP>2 </SUP>is CO<SUB>2</SUB>H, CH<SUB>2</SUB>CO<SUB>2</SUB>H, or esters, amides or isosteres thereof; R<SUP>3 </SUP>is a group capable of fitting into the S2 subsite of a caspase enzyme; R<SUP>4 </SUP>and R<SUP>5 </SUP>are taken together with the intervening nitrogen to form heterocyclic ring and R is as described in the specification. The compounds are effective inhibitors of apoptosis and IL-1beta secretion. |